Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles

Human Gene Therapy

Volumn 8, Issue 4, 1997, Pages 453-465

  Shabram, Paul W ^c   Giroux, Daniel D ^c   Goudreau, Ann M ^c   Gregory, Richard J ^a   Horn, Mark T ^c   Huyghe, Bernard G ^c   Liu, Xioadong ^c   Nunnally, Mary H ^b   Sugarman, Barry J ^c   Sutjipto, Suganto ^c  

^a GENZYME CORPORATION   (United States)

^b InVivoMetrics Inc   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS 5; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; GENE THERAPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VIRION; VIRUS PARTICLE; VIRUS RECOMBINANT;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 5;

EID: 16944365650     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.4-453     Document Type: Article

References (19)

1. BOULANGER, P.A., and PUVION, F. (1973). Large scale preparation of soluble adenovirus hexon, penton and fiber antigens in highly purified form. Env. J. Biochem. 39, 37-42.
2. GINSBERG, H.S., LUNDHOLM-BEAUCHAMP, U., HORSWOOD, R.L., PERNIS, B., WOLD, W.S.M., CHANOCK, R.M., and PRINCE, G.A. (1989). Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc. Natl. Acad. Sci. USA 86, 3823-3827.
3. GRAHAM, F.L., SMILEY, J., RUSSEL, W.C., and NARIN, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-72.
4. GREEN, M., PINA, M., KIMES, R., WENSIK, P., MACHATTIE, L., and THOMAS JR., C. (1967). Adenovirus DNA: 1. Molecular weight and conformation. Proc. Natl. Acad. Sci. USA 57, 1302-1309.
5. HARUNA, J., YAOSI, H., KONO, R., and WATANABE, I. (1961). Separation of adenovirus by chromatography on DEAE-cellulose. Virology 13, 264-267.
6. HEMSTROM, C., NORDQVIST, K., PETTERSSON, U., and VIRTANEN, A. (1988). Gene product of region E4 of adenovirus type 5 modulates accumulation of certain viral proteins. J. Virol. 62, 3258-3264.
7. HUYGHE, B.G., LIU, X., SUTJIPTO, S., SUGARMAN, B.J., HORN, M.T., SHEPARD, H.M., SCANDELLA, C.J., and SHABRAM, P.W. (1995). Purification of type 5 recombinant adenovirus encoding human p53 by column chromatography. Hum. Gene Ther. 6, 1403-1416.
8. JONES, N., and SHENK, T. (1978). Isolation of deletion and substitution mutants of adenovirus type 5. Cell 13, 181-188.
9. JONES, N., and SHENK, T. (1979). Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 17, 683-689.
10. KLEMPERER, H.G., and PETEIRA, H.G. (1959). Study of adenovirus antigen fractionation by chromatography on DEAE cellulose. Virology 9, 536-545.
11. LAVER, W.G., YOUNGHUSBAND, H.B., and WRIGLEY, N.G. (1971). Purification and properties of chick embryo lethal orphan virus (an avian adenovirus). Virology 45, 598-614.
12. LYNN, D. (1994). A BASIC computer program for analyzing endpoint assays. BioTechniques. 12, 880-881.
13. MAIZEL, JR., J., WHITE, D., and SCHARFF, M. (1968). The polypeptides of adenovirus 1: Evidence for multiple protein components in the virion and a comparison of types 2, 7A and 12. Virology 36, 115-125.
14. MARCH, K.L., MADISON, J.E., and TRAPNELL, B.C. (1995). Phar macokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: Modulation by poloxamer 407 and implications for cardiovascular gene therapy. Hum. Gene Ther. 6, 41-53.
15. OLIVER, C.J., SHORTRIDGE, K.F., and BELYAVIN, G. (1976). Diffusion coefficient and molecular weight of Type 5 adenovirus by photon correlation spectroscopy. Biochim. Biophys. Acta 437, 589-598.
16. PHILIPSON, L. (1960). Separation on DEAE cellulose of components associated with adenovirus reproduction. Virology 10, 459-465.
17. PHILIPSON, L. (1961). Adenovirus assay by the fluorescent cell-counting procedure. Virology 15, 263-268.
18. PHILIPSON, L. (1983). Structure and assembly of adenoviruses. In Current Topics in Microbiology and Immunology. Springer-Verlag, Berlin-Heidelberg. 109, 2-52.
19. WILLS, K., MANEVAL, D., MENZEL, P., HARRIS, M., SUTJIPTO, S., VAILLANCOURT, M., HUANG, W.-M., JOHNSON, D., ANDERSON, S., WEN, S.-F., BOOKSTEIN, R., SHEPARD, M., and GREGORY, R. (1994). Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Hum. Gene Ther. 5, 1079-1088.